10-98429811-C-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_000195.5(HPS1):​c.847G>C​(p.Gly283Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000335 in 1,613,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G283A) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.00052 ( 0 hom., cov: 33)
Exomes š‘“: 0.00032 ( 0 hom. )

Consequence

HPS1
NM_000195.5 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: -1.55

Publications

19 publications found
Variant links:
Genes affected
HPS1 (HGNC:5163): (HPS1 biogenesis of lysosomal organelles complex 3 subunit 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is a component of three different protein complexes termed biogenesis of lysosome-related organelles complex (BLOC)-3, BLOC4, and BLOC5. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 1. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on chromosome 22. [provided by RefSeq, Aug 2015]
HPS1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Hermansky-Pudlak syndrome with pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009726554).
BP6
Variant 10-98429811-C-G is Benign according to our data. Variant chr10-98429811-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 1188296.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPS1NM_000195.5 linkc.847G>C p.Gly283Arg missense_variant Exon 9 of 20 ENST00000361490.9 NP_000186.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPS1ENST00000361490.9 linkc.847G>C p.Gly283Arg missense_variant Exon 9 of 20 1 NM_000195.5 ENSP00000355310.4 Q92902-1
ENSG00000289758ENST00000699159.1 linkn.*227-169G>C intron_variant Intron 8 of 23 ENSP00000514167.1 A0A8V8TP71

Frequencies

GnomAD3 genomes
AF:
0.000519
AC:
79
AN:
152206
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00106
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000965
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000386
AC:
97
AN:
251054
AF XY:
0.000405
show subpopulations
Gnomad AFR exome
AF:
0.000801
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.000870
Gnomad FIN exome
AF:
0.0000463
Gnomad NFE exome
AF:
0.000370
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000316
AC:
462
AN:
1461492
Hom.:
0
Cov.:
34
AF XY:
0.000320
AC XY:
233
AN XY:
727064
show subpopulations
African (AFR)
AF:
0.000956
AC:
32
AN:
33480
American (AMR)
AF:
0.000380
AC:
17
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000765
AC:
2
AN:
26136
East Asian (EAS)
AF:
0.000403
AC:
16
AN:
39700
South Asian (SAS)
AF:
0.000267
AC:
23
AN:
86256
European-Finnish (FIN)
AF:
0.0000566
AC:
3
AN:
53046
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.000311
AC:
346
AN:
1111992
Other (OTH)
AF:
0.000364
AC:
22
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
29
57
86
114
143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000519
AC:
79
AN:
152324
Hom.:
0
Cov.:
33
AF XY:
0.000363
AC XY:
27
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00106
AC:
44
AN:
41588
American (AMR)
AF:
0.000392
AC:
6
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000967
AC:
5
AN:
5172
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68018
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000102
Hom.:
659
Bravo
AF:
0.000491
ExAC
AF:
0.000412
AC:
50
EpiCase
AF:
0.000273
EpiControl
AF:
0.000474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Mar 27, 2019
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Nov 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome Uncertain:1
Jan 24, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome 1 Uncertain:1
Mar 04, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
0.0010
DANN
Benign
0.40
DEOGEN2
Benign
0.052
T;T;T;.
Eigen
Benign
-2.5
Eigen_PC
Benign
-2.5
FATHMM_MKL
Benign
0.047
N
LIST_S2
Benign
0.24
.;.;T;T
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.0097
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.90
N;N;N;N
PhyloP100
-1.5
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.020
N;N;.;N
REVEL
Benign
0.013
Sift
Benign
0.68
T;T;.;T
Sift4G
Benign
0.57
T;T;T;T
Polyphen
0.0020
B;B;B;B
Vest4
0.11
MVP
0.085
MPC
0.17
ClinPred
0.00098
T
GERP RS
-5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.030
gMVP
0.18
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11592273; hg19: chr10-100189568; API